The diversity of cell types generated during development needs to be faithfully maintained for normal homeostatic tissue functions. How cells integrate developmental and signalling-dependent instructions to acquire or alter transcriptional states remains a fundamental question in developmental biology. Polycomb and Trithorax group members act as epigenetic regulators to maintain target gene silencing or activation, respectively. Remarkably, tissues are capable of restoring homeostasis upon damage or stress, with inherent chromatin alterations supporting dynamic regulation of cell states. We are investigating how developmental and signalling pathways translate into modulating chromatin states underlying distinct tissue responses.
Signalling pathways modulate developmental and regenerative processes but can also be exploited by cancer cells to promote tissue invasion and growth advantage. Motivated by the parallels between the two processes, we identified context-specific features that can discriminate regenerative from tumorigenic states. We explored the contribution of ectopic signalling pathways to promote tumour development upon impaired Polycomb silencing. We employed quantitative analyses to measure the effect of JNK, JAK/STAT and Notch pathways in a Drosophila epithelial tumour model and found that these pathways support tumour growth. Furthermore, JAK/STAT signalling functions in parallel to JNK, while Notch signalling relies on JNK. We thus defined a signalling hierarchy in tumours that is distinct from the sequential activation determined during tissue regeneration.
Furthermore, we are also developing novel methods for tissuespecific chromatin profiling of rare cell populations. These approaches overcome the current limitations of small tissue amounts, and can be generally applicable to a diverse array of organisms and developmental stages. The combination of emerging technologies with powerful genetics in a real tissue context will support mechanistic insights driving chromatin alterations during development and homeostasis. doi:10.1016/j.mod.2017.04.452 PS5.50 Wnt/B-catenin signalling facilitates cell fate decision making in the early mouse embryo Elena Corujo-Simon, Joaquin Lilao-Garzon, Silvia Muñoz-Descalzo
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Mouse pre-implantation development is characterized by cell division and differentiation to give rise to three different lineages: trophectoderm (TE), primitive endoderm (PrE) and epiblast (Epi).
The TE, which will differentiate into the placenta, arises at embryonic day E3.5d from cells situated outside of the embryo whilst inside cells form the inner cell mass (ICM). At this stage, ICM cells coexpress the transcription factors NANOG and GATA6. Between E3.5d and E4.5d, cells of the ICM differentiate into epiblast (Epi), which will form the embryo proper, or primitive endoderm (PrE), which will form the yolk sac. These two lineages are distinguished by the differential expression of the previously co-expressed transcription factors; Epi cells express NANOG while PrE cells GATA6.
β-catenin is the downstream effector of Wnt signalling, a widespread cell signalling pathway with multiple roles during vertebrate development. β-catenin is also found together with E-cadherin in adhesion complexes in the membrane. In mESCs, which origin is the mouse pre-implantation embryo, there is a dual role for β-catenin: it promotes differentiation when activated as part of the Wnt/β-catenin signalling pathway, and promotes stable pluripotency independently of signalling.
My working hypothesis is that changes in both cellular pools of β-catenin are involved in differentiation of ICM cells into either Epi or PrE. To investigate this hypothesis we use a combination of in vivo studies as well as a mESC model for PrE differentiation together with small molecule inhibitors and quantitative image analysis. Our results indicate that increases in nuclear β-catenin levels allow the cells to move further into the PrE fate, determined by the expression of GATA6, SOX17 and GATA4, while decreasing nuclear β-catenin levels slows the PrE differentiation.
Establishing a role for β-catenin in cell fate choice at this stage will help to understand cellular differentiation and how different lineages arise in mouse development. Ryk is a member of atypical receptor tyrosine kinase family that consists of an extracellular WIF (Wnt inhibitory factor) domain, an intracellular atypical kinase domain, and a PDZ binding motif at C-terminus. Ryk has previously been shown to regulate canonical Wnt/β-catenin signaling by directly binding to Wnt ligands and Dishevelled. A recent study showed that Ryk also regulates noncanonical Wnt pathway in convergent extension (CE) movements by promoting Wnt11-mediated endocytosis. However, downstream signaling mechanism of Ryk receptor still remain to be resolved in detail. In this study, we tried to identify binding proteins of Ryk by using IP-Mass method. To identify novel binding partners of Ryk receptor, HEK 293T cells were transfected with (1) empty vector, (2) Ryk-myc, (3) Ryk-myc + canonical Wnt 3a and (4) Ryk-myc + non-canonical Wnt11. Then, IP was performed using myc antibody and putative Ryk binding proteins were identified by LC-MS. We found several novel proteins that may interact with Ryk receptor as well as previously known binding partners such as Cdc37 and EphA4. The heart is the first organ to form and function during mammalian development. Recently we established that in the mouse embryo, spontaneous asynchronous calcium oscillations (SACOs) occour in the cardiac crescent prior to the onset of cardiac contractions. Blocking Sodium Calcium Exchanger (NCX1) function inhibits these oscillations and cardiac differentiation.
The genetic control of the physiological dynamics observed in the cardiac mesoderm, and how these are integrated to control cardiac differentiation, remains unknown. By imaging the propagation of calcium transients in the cardiac crescent, we now have evidence of left-right asymmetry in the directionality of calcium transients prior to any morphological break of symmetry. This represents a previously unknown L/R functional asymmetry in the developing embryo.
To gain a better insight into the initiation and regulation of this process during development, we are performing a detailed spatial and temporal transcriptional analysis of cardiac crescent development using single-cell RNAseq (scRNA-seq). We have sequenced over 2000 single cells from left and right portions of the cardiac crescent separately, spanning four stages of cardiac crescent maturation prior to the formation of the linear heart tube. Using bioinformatic analyses we identified several candidate genes potentially responsible for the processes mentioned above. Complimentary Calcium imaging of chick embryonic hearts revealed a different dynamic in terms of the left-right propagation of the calcium transients and the timing of the first heartbeats. We therefore performed qRT-PCR on chick and mouse embryonic hearts in order to identify the pathways likely to be responsible for the mouse specific physiological behaviors we have observed. I will present an overview of the genetic regulatory networks involved in the developmental physiology of the embryonic heart. Morphogens determine cell fate in a concentration dependent manner. Developing tissues are often dynamic and it is unclear how morphogens reliably determine cell fate in such contexts. We address this problem using as a model the specification of muscle fibre types by the morphogens Shh, BMP and FGF in the zebrafish embryo. FGF reportedly determines the allocation of slow-twitch fibre progenitors to the Muscle Pioneer (MP) fate as a function of position along the anterior-posterior axis, yet by cell tracking, we find no anterior-posterior bias in their induction. Nevertheless, inhibition of the FGF pathway does increase MP number. FGF pathway inhibition delays fast-twitch muscle fibre elongation and extrusion, which we show subsequently hinders migration of slowtwitch progenitors away from MPs. This delay results in increased MP number, likely due to prolonged Shh exposure. Thus, FGF nonautonomously determines MP cell fate through regulating the precise temporal migration of different cell types. pathway, activates downstream signal transduction directly through small G α protein is still in dispute. Interestingly, several new orphan GPCRs, including Gpr161, have been identified as regulators of Hedgehog signaling pathway, however, through different G α proteins. These studies raise the questions that which G α plays major role, and how these G α protein with different effects work together in Hh signal transduction? To address these questions, CRISPRCas9 DNA editing tool will be employed to generate null mutant of different G α proteins in both zebrafish and mouse tissue culture. Intensively genetic, biochemical and cellular analyses will be performed to assay the Hh signaling pathway activity in all single mutants and possible double mutants to dissect G α protein function in regulating Hh activity. In addition, in order to effectively examine the correlation between PKA activity and Hh pathway activity, stable cell lines and transgenic zebrafish carrying primary cilium (PC) compartment PKA activity reporter construct will be generated by combining the nephronophthisis 3 N terminal and PKA reporter substrate AKAR2. Using these transgenic lines, molecular mechanism of the Hh pathway will be substantially examined. These works will provide: 1) important evidence for understanding of the mechanism of Hh signal transduction; 2) new clues for identification of potential GPCRs involved in Hh pathway in different tissues and cells. Adult hippocampal neural stem cells (AH-NSCs) predominantly exist as non-proliferative quiescent neural progenitors that transition into a proliferative state during neurogenesis. It is important to understand the molecular regulation of activation of AH-NSCs to target them for neurodegenerative medicine and therapeutic intervention in brain tumor cancer stem cells. In the present study, we have taken an omics approach to understand the molecular regulation of cellular translation or ribosome biogenesis and cell cycle in stem cells from the perspective of transcription. Work from our lab and others have identified several key transcription factors (REST, ASCL1, OLIG2, SOX family, MAX, TCF3 and NFI), and their binding sites in AH-NSCs using chromatin immunoprecipitation (ChIP)-sequencing. RNA-seq analysis of gene expression showed that cell cycle and ribosome biogenesis are major gene ontologies upregulated in activated AH-NSCs. Here we combined ChIP-seq and RNA-seq omics approaches to identify distinct subset of genes within ribosome biogenesis and cell cycle genes, regulated by distinct transcription factors in activated AH-NSCs. Moreover, we functionally validated several cell cycle and ribosome biogenesis genes to show that they are sufficient, alone and in synergy to induce proliferation in AH-NSCs. Here we have shown the utility of mining DNA binding and transcriptomics data to gain a comprehensive view of regulation of AH-NSCs. Furthermore, we have established a regulatory link between cellular transcription and translation, through transcription factor mediated gene expression regulation of translation factors. This approach can identify candidate genes for drug development that hit both the transcriptional and translational hot-spots dysregulated in diseases. Supported by NIH grants R01AG032383, R21MH094715, and K02AG041815 and Welch Foundation I-1660. doi:10.1016/j.mod.2017.04.458
